Compare Aventis Pharma with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs PFIZER - Comparison Results

SANOFI INDIA     Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA PFIZER SANOFI INDIA/
PFIZER
 
P/E (TTM) x 44.2 37.1 119.2% View Chart
P/BV x 8.1 6.3 129.2% View Chart
Dividend Yield % 1.1 0.5 197.4%  

Financials

 SANOFI INDIA   PFIZER
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
PFIZER
Mar-19
SANOFI INDIA/
PFIZER
5-Yr Chart
Click to enlarge
High Rs6,8403,840 178.1%   
Low Rs4,6302,080 222.6%   
Sales per share (Unadj.) Rs1,203.1455.0 264.4%  
Earnings per share (Unadj.) Rs165.393.8 176.2%  
Cash flow per share (Unadj.) Rs209.9109.4 191.9%  
Dividends per share (Unadj.) Rs84.0022.50 373.3%  
Dividend yield (eoy) %1.50.8 192.7%  
Book value per share (Unadj.) Rs963.6658.2 146.4%  
Shares outstanding (eoy) m23.0345.75 50.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.86.5 73.3%   
Avg P/E ratio x34.731.6 109.9%  
P/CF ratio (eoy) x27.327.1 101.0%  
Price / Book Value ratio x6.04.5 132.3%  
Dividend payout %50.824.0 211.9%   
Avg Mkt Cap Rs m132,078135,420 97.5%   
No. of employees `0003.32.6 125.5%   
Total wages/salary Rs m4,0683,238 125.6%   
Avg. sales/employee Rs Th8,393.87,911.4 106.1%   
Avg. wages/employee Rs Th1,232.41,230.9 100.1%   
Avg. net profit/employee Rs Th1,153.01,630.7 70.7%   
INCOME DATA
Net Sales Rs m27,70820,815 133.1%  
Other income Rs m8971,674 53.6%   
Total revenues Rs m28,60522,489 127.2%   
Gross profit Rs m6,2355,712 109.2%  
Depreciation Rs m1,027714 143.9%   
Interest Rs m773 9.6%   
Profit before tax Rs m6,0986,599 92.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2922,309 99.3%   
Profit after tax Rs m3,8064,291 88.7%  
Gross profit margin %22.527.4 82.0%  
Effective tax rate %37.635.0 107.4%   
Net profit margin %13.720.6 66.6%  
BALANCE SHEET DATA
Current assets Rs m15,92227,167 58.6%   
Current liabilities Rs m6,2358,917 69.9%   
Net working cap to sales %35.087.7 39.9%  
Current ratio x2.63.0 83.8%  
Inventory Days Days6468 93.9%  
Debtors Days Days2130 69.3%  
Net fixed assets Rs m7,5398,862 85.1%   
Share capital Rs m230458 50.3%   
"Free" reserves Rs m21,96229,656 74.1%   
Net worth Rs m22,19230,113 73.7%   
Long term debt Rs m025 0.0%   
Total assets Rs m29,83939,400 75.7%  
Interest coverage x872.191.5 952.9%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.90.5 175.8%   
Return on assets %12.811.1 115.4%  
Return on equity %17.214.2 120.4%  
Return on capital %27.522.1 124.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m7,587428 1,771.4%   
Fx outflow Rs m7,145786 908.6%   
Net fx Rs m442-358 -123.4%   
CASH FLOW
From Operations Rs m3,739978 382.3%  
From Investments Rs m-731351 -208.1%  
From Financial Activity Rs m-1,972-1,099 179.5%  
Net Cashflow Rs m1,036231 448.9%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 60.4 63.9 94.5%  
Indian inst/Mut Fund % 14.4 7.5 192.0%  
FIIs % 14.6 4.9 298.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 23.7 44.3%  
Shareholders   15,184 85,207 17.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   AUROBINDO PHARMA  ORCHID PHARMA LTD  GSK PHARMA  J.B.CHEMICALS  PROCTER & GAMBLE HEALTH  

Compare SANOFI INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 178 Points Higher; Telecom and Power Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest throughout the day today and ended on a positive note.

Related Views on News

SANOFI INDIA Announces Quarterly Results (4QFY20); Net Profit Down 8.1% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, SANOFI INDIA has posted a net profit of Rs 854 m (down 8.1% YoY). Sales on the other hand came in at Rs 8 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

PFIZER Announces Quarterly Results (3QFY20); Net Profit Up 5.4% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, PFIZER has posted a net profit of Rs 1 bn (up 5.4% YoY). Sales on the other hand came in at Rs 5 bn (up 4.7% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY20); Net Profit Down 2.2% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, SANOFI INDIA has posted a net profit of Rs 974 m (down 2.2% YoY). Sales on the other hand came in at Rs 7 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How...(Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Jul 3, 2020 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA - STERLING BIOTECH COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS